Watch VIVS. Know when insiders buy.
One email the day a filing lands. Free.
VIVS
VivoSim Labs, INC.
0.18
+0.01 +4.12%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
61
WATCH · insiders 55, shorts 66
Insiders, 90 days
+$3K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.6MP/E —DIV YIELD —FCF YIELD -385.12%REV TTM $112K −21.1%NET INCOME −$12.3MNET CASH —52W 0.16 – 2.98SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | $18K | −51.4% | — | −$2.8M | −$1.3M | — | -0.25 | −$3.2M | $23K | −$3.2M | Aug 12 |
| Q4 2026 · Mar 31derived | $40K | −21.6% | 100.0% | −$3.2M | −$5.8M | −184.1% | -2.21 | −$2.2M | $0 | −$2.2M | Jul 14 |
| Q3 2026 · Dec 31 | $26K | +8.3% | 100.0% | −$2.8M | −$2.7M | — | -1.03 | −$2.3M | $0 | −$2.3M | Feb 11 |
| Q2 2026 · Sep 30 | $28K | −6.7% | 100.0% | −$2.6M | −$2.5M | — | -0.98 | −$2.4M | $0 | −$2.4M | Nov 6 |
| Q1 2026 · Jun 30 | $37K | −5.1% | 100.0% | −$2.9M | −$2.8M | — | -1.14 | −$3.9M | $0 | −$3.9M | Aug 12 |
| Q4 2025 · Mar 31derived | $51K | +75.9% | 100.0% | −$3.2M | $6.9M | — | 4.90 | −$2M | $0 | −$2M | Jul 14 |
| Q3 2025 · Dec 31 | $24K | +380.0% | 91.7% | −$3.5M | −$3.4M | — | -2.28 | −$1.8M | $0 | −$1.8M | Feb 11 |
| Q2 2025 · Sep 30 | $30K | — | 96.7% | −$2.6M | −$2.5M | — | -1.68 | −$2.6M | $13K | −$2.7M | Nov 6 |
| Q1 2025 · Jun 30 | $39K | — | 94.9% | −$3.4M | −$3.3M | — | -2.74 | −$3M | $0 | −$3M | Aug 12 |
| Q4 2024 · Mar 31derived | $29K | — | — | −$3.1M | −$3M | — | -17.94 | −$2.7M | $0 | −$2.7M | Jun 5 |
| Q3 2024 · Dec 31 | $5K | — | 100.0% | −$3.7M | −$3.6M | — | -0.40 | −$3.5M | $0 | −$3.5M | Feb 19 |
| Q2 2024 · Sep 30 | $0 | — | — | −$4.1M | −$4M | — | -0.46 | −$3.1M | $27K | −$3.2M | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | $131K | 100.0% | −$11.5M | −$13.8M | -10567.2% | -5.35 | −$10.8M | $0 | −$10.8M | — | — |
| FY2025 · to Mar 31 | $144K | 96.5% | −$12.6M | −$2.5M | -1727.8% | -1.70 | −$9.5M | $13K | −$9.5M | — | — |
| FY2024 · to Mar 31 | $109K | — | −$15.1M | −$14.7M | -13459.6% | -19.25 | −$14.7M | $42K | −$14.7M | — | — |
| FY2023 · to Mar 31 | $370K | — | −$17.7M | −$17.3M | -4664.6% | -1.98 | −$12.4M | $396K | −$12.8M | — | — |
| FY2022 · to Mar 31 | $1.5M | — | −$11.5M | −$11.4M | -763.2% | -1.32 | −$8.5M | $409K | −$8.9M | $0 | — |
| FY2021 · to Mar 31 | $0 | — | −$16.8M | −$16.8M | — | -2.44 | −$13.3M | $405K | −$13.7M | $1K | — |
Every number comes from VivoSim Labs, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.